Latest Pradaxa news
Dabigatran May Be Better Than Warfarin After Bleeding Episode
posted December 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Dabigatran is less likely than warfarin to cause recurrent bleeding in atrial fibrillation patients who have experienced a major bleeding event, according to a study published online Dec. 1 in Stroke.
Higher Bleeding Risk Seen With Rivaroxaban Versus Dabigatran
posted October 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Rivaroxaban may pose a slightly greater risk of serious bleeding than dabigatran in patients with atrial fibrillation, according to a study published online Oct. 3 in JAMA Internal Medicine.
Editor's Recommendations
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis 
NOACs Linked to Slower Cognitive Decline in Patients With A-Fib, Alzheimer Disease 
Central Adiposity Reclassifies Cardiovascular Risk Across BMI Spectrum 
Physical Activity Reduces Stroke, Mortality, Regardless of A-Fib Related Articles
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk 
Exercise-Based Cardiac Rehab Beneficial for Coronary Heart Disease 
Isometric Exercise Training Three Times a Week Preserves Cardiovascular Benefits 
UACR, UPCR Provide Indistinguishable Prognostic Information in CKD Monthly Specialist Briefings
Stay Connected
